# Handling Oxygenation Targets in COVID-19

> **NCT04425031** · PHASE4 · COMPLETED · sponsor: **Aalborg University Hospital** · enrollment: 726 (actual)

## Conditions studied

- Hypoxemic Respiratory Failure
- Oxygen Toxicity

## Interventions

- **DRUG:** Low oxygenation target
- **DRUG:** High oxygenation target

## Key facts

- **NCT ID:** NCT04425031
- **Lead sponsor:** Aalborg University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-25
- **Primary completion:** 2023-03-08
- **Final completion:** 2024-03-08
- **Target enrollment:** 726 (ACTUAL)
- **Last updated:** 2024-07-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04425031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04425031, "Handling Oxygenation Targets in COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04425031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*